文献速递血液透析通路

动静脉瘘动脉瘤修复同期流入道修正或流出道血运重建的中期结局

Midterm outcomes of arteriovenous fistula aneurysm repair with simultaneous inflow revision or outflow tract revascularization.
PubMed 文献 · J Vasc Surg · 2023-11-11

这项回顾性队列研究在三级转诊中心纳入93例需修复的动脉瘤型动静脉瘘血液透析患者,随访至少2年,主要终点为累积通畅率。2年一期、一期辅助和累积通畅率分别为60%±1%、91%±3%和94%±3%,作者认为同期动脉瘤修复、流入道修正和流出道血运重建的扩大范围动静脉瘘修复可行、安全且2年通畅率良好。

要点

  • 93例动脉瘤型动静脉瘘患者中,95%行动脉瘤缝缩术,53%行流入道修正,72%处理流出道梗阻。
  • 2年累积通畅率94%±3%,2年免于动脉瘤相关再干预率95%±3%。
  • 首次再干预最常见指征为流出道狭窄(24%),随访期间动脉瘤复发13例(14%)。

核心结论

  • 同期行动脉瘤修复、流入道修正和流出道血运重建的扩大范围动静脉瘘修复可行、安全,并与良好的2年通畅率相关。

研究设计与样本

  • 回顾性队列研究,在三级转诊中心纳入93例需修复的动脉瘤型动静脉瘘血液透析患者,入组条件为年龄≥18岁且动脉瘤修复同时行流入道修正或流出道病变治疗,随访至少2年,主要终点为累积通畅率。

主要发现

  • 队列平均年龄56±12岁,最常见通路类型为头臂型动静脉瘘(61%),修正时通路中位年龄66个月(四分位距46-93个月)。
  • 通路中位流量2300 ml/min(四分位距1281-2900),31例(33%)的动脉瘤同时与高流量和静脉梗阻相关。
  • 动脉瘤修复绝大多数为动脉瘤缝缩术(95%),流入道修正共49例(53%),流出道梗阻治疗71例(72%),27例(29%)接受同期三组件修正。
  • 2年一期、一期辅助和累积通畅率分别为60%±1%、91%±3%和94%±3%。
  • 首次再干预最常见指征为流出道狭窄(24%);整个随访期间动脉瘤复发13例(14%),其中7例(8%)因此再干预,2年免于动脉瘤相关再干预率为95%±3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate the 2-year outcomes of extensive revisions aimed at simultaneously addressing arteriovenous fistula (AVF) aneurysms, outflow stenosis, and/or high flow volumes. METHODS: This was a retrospective cohort study in a tertiary referral center. The study population comprised hemodialysis patients with aneurysmal AVFs requiring revision. Subjects were eligible if they were ≥18 years of age and had aneurysm repair associated with inflow revision or treatment of outflow lesions. Patients were followed-up for a minimum of 2 years, and the primary outcome measure was cumulative patency. RESULTS: Our cohort comprised 93 patients with a mean age of 56 ± 12 years. The most frequent access type was brachiocephalic fistula (61%), and the median access age at the time of revision was 66 months (interquartile range, 46-93 months). The median access flow volume was 2300 ml/min (interquartile range, 1281-2900), and 31 subjects (33%) presented aneurysms associated with both high flow and venous obstruction. Aneurysm repair consisted of aneurysmorraphy in the overwhelming majority (95%). Inflow revision was performed in a total of 49 cases (53%), and outflow tract obstruction was treated in 71 patients (72%), with 27 patients (29%) receiving a simultaneous 3-component revision. At 2 years, the primary, primary assisted, and cumulative patencies were 60% ± 1%, 91% ± 3%, and 94% ± 3%, respectively. The most frequent indication for first-time reinterventions was outflow tract stenosis (24%). Aneurysm recurrence was observed in 13 subjects (14%) during the entire follow-up and was responsible for reinterventions in seven of them (8%), with a 2-year freedom from aneurysm-related reintervention rate of 95% ± 3%. CONCLUSIONS: Extensive AVF revision with simultaneous aneurysm repair, inflow revision, and outflow tract revascularization is feasible, safe, and associated with favorable 2-year patency rates.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Benfor B, Singh T, Puppala R, et al. Midterm outcomes of arteriovenous fistula aneurysm repair with simultaneous inflow revision or outflow tract revascularization. J Vasc Surg. 2023. PMID: 37956959. doi:10.1016/j.jvs.2023.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。